Showing results (91-100 of 428) with videos related to
Sort By:
Pageof 43
Current Oncology (Toronto, Ont.)|June 27, 2023
Translational Models in Glioma Immunotherapy ResearchAlexander L Ren, Janet Y Wu, Si Yeon Lee, et al.Open Forum Infectious Diseases|July 16, 2016
Nontyphoidal Salmonellosis, Human Immunodeficiency Virus Infection, and Ischemic StrokeDamani A Piggott, Karen C Carroll, Michael Lim, et al.Journal of Immunology Research|May 8, 2014
Current vaccine trials in glioblastoma: a reviewLinda W Xu, Kevin K H Chow, Michael Lim, et al.JBJS Case Connector|November 26, 2025
The Devil is in the Details-Near-Miss Wrong-Level Thoracic Spine Surgery Despite Robotic Navigation: A Case ReportMichael Lim, Lawal Labaran, Ved A Vengsarkar, et al.Frontiers in Immunology|May 21, 2026
Biomarkers for predicting immunotherapy response and resistance in glioblastomaSamuel Kim, Matthew Abikenari, Brandon Bergsneider, et al.Skull Base : Official Journal of North American Skull Base Society ... [Et Al.]|February 12, 2011
Transpalpebral orbitofrontal craniotomy: a minimally invasive approach to anterior cranial vault lesionsKofi D Owusu Boahene, Michael Lim, Eugene Chu, et al.Neurosurgical Focus|August 27, 2004
Efficacy and safety of stereotactic radiosurgery for glomus jugulare tumorsMichael Lim, Iris C Gibbs, John R Adler, et al.Neuro-Oncology Advances|November 13, 2024
The landscape of immune checkpoint inhibitor clinical trials in glioblastoma: A systematic reviewEthan Schonfeld, John Choi, Andrew Tran, et al.Cancer Immunology Research|August 12, 2024
The CCR6-CCL20 Axis Promotes Regulatory T-cell Glycolysis and Immunosuppression in TumorsAyush Pant, Aanchal Jain, Yiyun Chen, et al.Nature Medicine|July 10, 2026
Anti-LAG-3 with or without anti-PD-1 in recurrent glioblastoma: a phase 1 trialMichael Lim, Xiaobu Ye, Anna F Piotrowski, et al.Pageof 43